Update and harmonisation of guidance for the management of diabetic ketoacidosis in children and young people in the UK

Diabetic ketoacidosis (DKA) is a life-threatening complication of type 1 diabetes mellitus. Careful and timely intervention is required to optimise glycaemic control and reduce the risk of mortality and devastating complications. Of these, cerebral oedema is the leading cause of death, with a mortal...

Description complète

Enregistré dans:

Détails bibliographiques
Auteur principal:	Mark Deakin
Format:	article
Langue:	EN
Publié:	BMJ Publishing Group 2021
Sujets:	Pediatrics RJ1-570
Accès en ligne:	https://doaj.org/article/f18e64c7925c47d792dc02ed007af5a9
Tags:	Ajouter un tag Pas de tags, Soyez le premier à ajouter un tag!

id	oai:doaj.org-article:f18e64c7925c47d792dc02ed007af5a9
record_format	dspace
spelling	oai:doaj.org-article:f18e64c7925c47d792dc02ed007af5a92021-11-05T07:00:07ZUpdate and harmonisation of guidance for the management of diabetic ketoacidosis in children and young people in the UK10.1136/bmjpo-2021-0010792399-9772https://doaj.org/article/f18e64c7925c47d792dc02ed007af5a92021-11-01T00:00:00Zhttps://bmjpaedsopen.bmj.com/content/5/1/e001079.fullhttps://doaj.org/toc/2399-9772Diabetic ketoacidosis (DKA) is a life-threatening complication of type 1 diabetes mellitus. Careful and timely intervention is required to optimise glycaemic control and reduce the risk of mortality and devastating complications. Of these, cerebral oedema is the leading cause of death, with a mortality rate of approximately 25%. This article highlights the recent updates to UK fluid therapy guidelines for DKA and provides clinical context for the benefit of paediatricians and junior doctors in light of this new guidance.Mark DeakinBMJ Publishing GrouparticlePediatricsRJ1-570ENBMJ Paediatrics Open, Vol 5, Iss 1 (2021)
institution	DOAJ
collection	DOAJ
language	EN
topic	Pediatrics RJ1-570
spellingShingle	Pediatrics RJ1-570 Mark Deakin Update and harmonisation of guidance for the management of diabetic ketoacidosis in children and young people in the UK
description	Diabetic ketoacidosis (DKA) is a life-threatening complication of type 1 diabetes mellitus. Careful and timely intervention is required to optimise glycaemic control and reduce the risk of mortality and devastating complications. Of these, cerebral oedema is the leading cause of death, with a mortality rate of approximately 25%. This article highlights the recent updates to UK fluid therapy guidelines for DKA and provides clinical context for the benefit of paediatricians and junior doctors in light of this new guidance.
format	article
author	Mark Deakin
author_facet	Mark Deakin
author_sort	Mark Deakin
title	Update and harmonisation of guidance for the management of diabetic ketoacidosis in children and young people in the UK
title_short	Update and harmonisation of guidance for the management of diabetic ketoacidosis in children and young people in the UK
title_full	Update and harmonisation of guidance for the management of diabetic ketoacidosis in children and young people in the UK
title_fullStr	Update and harmonisation of guidance for the management of diabetic ketoacidosis in children and young people in the UK
title_full_unstemmed	Update and harmonisation of guidance for the management of diabetic ketoacidosis in children and young people in the UK
title_sort	update and harmonisation of guidance for the management of diabetic ketoacidosis in children and young people in the uk
publisher	BMJ Publishing Group
publishDate	2021
url	https://doaj.org/article/f18e64c7925c47d792dc02ed007af5a9
work_keys_str_mv	AT markdeakin updateandharmonisationofguidanceforthemanagementofdiabeticketoacidosisinchildrenandyoungpeopleintheuk
_version_	1718444505601933312

Update and harmonisation of guidance for the management of diabetic ketoacidosis in children and young people in the UK

Documents similaires